Csenge Advisory Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-427
| Closed | -$211K | – | 610 |
|
|
2022
Q2 | $211K | Sell |
427
-54
| -11% | -$26.7K | 0.02% | 530 |
|
|
2022
Q1 | $271K | Buy |
481
+29
| +6% | +$16.3K | 0.02% | 519 |
|
|
2021
Q4 | $297K | Buy |
452
+1
| +0.2% | +$657 | 0.03% | 455 |
|
|
2021
Q3 | $335K | Sell |
451
-1
| -0.2% | -$743 | 0.03% | 446 |
|
|
2021
Q2 | $297K | Sell |
452
-5
| -1% | -$3.29K | 0.03% | 456 |
|
|
2021
Q1 | $275K | Buy |
457
+17
| +4% | +$10.2K | 0.03% | 407 |
|
|
2020
Q4 | $256K | Sell |
440
-34
| -7% | -$19.8K | 0.03% | 358 |
|
|
2020
Q3 | $253K | Buy |
474
+31
| +7% | +$16.5K | 0.03% | 327 |
|
|
2020
Q2 | $200K | Buy |
+443
| New | +$200K | 0.03% | 357 |
|
|
2018
Q4 | – | Sell |
-30
| Closed | -$8K | – | 345 |
|
|
2018
Q3 | $8K | Buy |
+30
| New | +$8K | ﹤0.01% | 539 |
|